Christopher B. Ehrlich - 06 Oct 2021 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Issuer symbol
EFTR
Transactions as of
06 Oct 2021
Net transactions value
$0
Form type
4
Filing time
08 Oct 2021, 17:22:23 UTC
Previous filing
05 Oct 2021
Next filing
12 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFTR Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 06 Oct 2021 Common Stock 40,000 $11.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in substantially equal monthly installments over three years, commencing on August 25, 2021, subject to the Reporting Person's continued service with the Issuer through each vesting date.